Neurofibromatosis Type 2 (NF2)
Neurofibromatosis type 2 (NF2) is a rare genetic disorder characterized by the growth of noncancerous tumors throughout the nervous system, particularly in the brain and spinal cord.
Causes and Genetics
NF2 is caused by a mutation in the NF2 gene, which provides instructions for making a protein called merlin or schwannomin. This protein acts as a tumor suppressor, helping to regulate cell growth and division. The mutation leads to the production of a nonfunctional protein, resulting in uncontrolled cell growth and tumor formation.
NF2 is inherited in an autosomal dominant pattern, meaning that a single copy of the mutated gene is sufficient to cause the condition. Each child of an affected parent has a 50% chance of inheriting the mutated gene.
Symptoms
The symptoms of NF2 typically begin in late childhood or early adulthood and may include:
- Hearing loss, which can be progressive and lead to deafness
- Balance problems and dizziness (vestibular dysfunction)
- Tinnitus (ringing or other sounds in the ears)
- Weakness or numbness in the face, arms, or legs
- Difficulty with speech and swallowing
- Headaches and seizures
- Skin tumors or nodules
Diagnosis
Diagnosis of NF2 is based on a combination of clinical evaluation, imaging studies, and genetic testing. The diagnostic criteria for NF2 include:
- Bilateral vestibular schwannomas (tumors on both auditory nerves)
- Family history of NF2
- Presence of multiple meningiomas (tumors in the membranes surrounding the brain and spinal cord) or ependymomas (tumors in the spinal cord)
- Genetic testing to identify a mutation in the NF2 gene
Treatment and Management
Treatment for NF2 is typically focused on managing symptoms and preventing complications. This may include:
- Surgery to remove tumors, particularly vestibular schwannomas
- Radiation therapy to slow tumor growth
- Physical therapy to improve balance and mobility
- Audiological rehabilitation to address hearing loss
- Pain management for chronic pain
Prognosis
The prognosis for individuals with NF2 varies depending on the severity of symptoms, the number and location of tumors, and the effectiveness of treatment. With proper management, many people with NF2 can lead active and productive lives, although they may experience significant disability and reduced life expectancy.
Frequently Asked Questions (FAQs)
What is Neurofibromatosis type 2 (NF2)?
A rare genetic disorder that causes tumors to form on nerve tissue.
What are the main symptoms of NF2?
Hearing loss, balance problems, and tumors on the nerves.
What type of tumors occur in NF2?
Benign tumors, such as schwannomas and meningiomas.
Where do these tumors typically occur?
On the vestibulocochlear nerve, brain, and spinal cord.
Is NF2 inherited?
Yes, it is an autosomal dominant genetic disorder.
What is the incidence of NF2?
About 1 in 25,000 to 1 in 40,000 people.
Can NF2 be diagnosed prenatally?
Yes, through genetic testing.
How is NF2 typically diagnosed?
Through MRI scans and genetic testing.
Is there a cure for NF2?
No, but symptoms can be managed with surgery and other treatments.
What are the main treatment options for NF2?
Surgery, radiation therapy, and physical therapy.
Article last updated on: 25th June 2025.
If you have any feedback, please get in touch.
See more
Diagnosis Pad
Medical AI Assistant with Differentials, Guidance, Transcriptions, Notes, Medical Encyclopedia and Explainable AI.
Medical AI Assistant with Differentials, Guidance, Transcriptions, Notes, Medical Encyclopedia and Explainable AI.
Medical Disclaimer
The information provided is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you have read on this site. We we do not guarantee, and assume no legal liability or responsibility for the accuracy, currency, or completeness of the information provided.